DUBLIN--(BUSINESS WIRE)--Aug 17, 2018--The “The Overview of Japanese CMO/CDMO Market - 2018” report has been added to ResearchAndMarkets.com’s offering
This report is an overview of Japanese CMO (contract manufacturing organization) CDMO (contract development and manufacturing organization) market. The reader will get insights into related regulations, market size, major players, and future prospects in this market.
Key Topics Covered:
2. Definition of CMO/CDMO
3. Laws and Regulations Related to CMOs
4. Main Industry Group
5. CMO Market Scale
6. CMO Market Share
7. Main CMOs
8. Nipro Pharma
9. Bushu Pharmaceuticals
10. Teikoku Seiyaku
11. CMIC CMO
12. Catalent Japan
15. Other CMOs
16. Outsourcing Trend from Pharma
17. Trend of pharmas’ selling/closing Factories
18. Market Entry from Generic Firms
19. Market Entry from Drug makers
20. OEM? CMO?
21. CMO is profitable enough?
22. Why non-Japanese CDMO have had low presence in Japan?
23. Shift to biopharmaceuticals
24. Future Prospects
For more information about this report visit https://www.researchandmarkets.com/research/z3w3sb/overview_of?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180817005079/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Pharmaceutical Manufacturing
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 08/17/2018 03:57 AM/DISC: 08/17/2018 03:56 AM